← Leaderboards
David John Hunter
Brigham And Women'S Hospital
$28,422,931
Attributed
$28,422,931
Total exposure
16
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.8M · FY2005–14$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$38,997,327 · 17
By mechanism
U19$11,191,546 · 2
U01$10,808,326 · 1
U54$7,011,460 · 1
R01$5,855,186 · 2
P01$1,796,634 · 3
P50$1,434,364 · 1
Top collaborators
- Habibul Ahsan5 shared
- Joan Siefert Brugge5 shared
- Stephen J Chanock5 shared
- Jack Cuzick5 shared
- Douglas Frederick Easton5 shared
- Matthew L Freedman5 shared
- Judy Ellen Garber5 shared
- David E. Goldgar5 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Nobuhiko Hata$5,976,509
- Mark A. Rubin$21,732,421
- Elizabeth W Karlson$93,612,751
- Debra A Schaumberg$6,275,999
- Gary C. Curhan$15,291,553
Others in their field
Top investigators on “Cancer Risk”
- Gregory H Reaman · National Childhood Cancer Foundation$242,495,090
- David Heimbrook · Leidos Biomedical Research, Inc.$222,048,828
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Philip J Disaia · University Of California Irvine$144,085,463
- Mitchell D Schnall · University Of Pennsylvania$138,156,012
- Peter C Adamson · National Childhood Cancer Foundation$128,266,602
Research focus
Cancer RiskGenesNeoplasm /Cancer GeneticsGenotypeMalignant NeoplasmsClinical ResearchGene Environment InteractionResearch PersonnelWomanGenetic PolymorphismCohortBiologicalRisk FactorsGenome Wide Association StudyInheritedResourcesVariantGenome-WideFollow-Up StudiesNurses&AposHealth StudyCommunitiesGeneticPhenotype
Grant awards (65)
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$574,120
U19 · FY2014 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$2,309,806
U19 · FY2013 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$144,986
U19 · FY2013 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$2,486,910
U19 · FY2012 · CA · contact PI
Correlating Environmental & Genetic Risk Factors with Molecular Signatures in$265,135
P50 · FY2012 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$170,587
U19 · FY2012 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$2,465,094
U19 · FY2011 · CA · contact PI
Correlating Environmental & Genetic Risk Factors with Molecular Signatures in$298,054
P50 · FY2011 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$147,552
U19 · FY2011 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$2,738,466
U19 · FY2010 · CA · contact PI
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3$1,135,499
U01 · FY2010 · CA · contact PI
Cohort Study of Genetic Susceptibility to Breast Cancer$409,590
R01 · FY2010 · CA · contact PI
Correlating Environmental & Genetic Risk Factors with Molecular Signatures in$312,523
P50 · FY2010 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$154,025
U19 · FY2010 · CA · contact PI
Bracing the Patellofemoral Osteoarthritis: A Clinical Trial$59,938
P60 · FY2010 · AR · contact PI
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3$1,403,224
U01 · FY2009 · CA · contact PI
Cohort Study of Genetic Susceptibility to Breast Cancer$408,636
R01 · FY2009 · CA · contact PI
Correlating Environmental & Genetic Risk Factors with Molecular Signatures in$314,830
P50 · FY2009 · CA · contact PI
GENETIC ANALYSIS AND SAMPLE HANDLING$301,658
P01 · FY2009 · CA · contact PI
Bracing the Patellofemoral Osteoarthritis: A Clinical Trial$130,621
P60 · FY2009 · AR · contact PI
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3$1,555,544
U01 · FY2008 · CA · contact PI
Cohort Study of Genetic Susceptibility to Breast Cancer$408,468
R01 · FY2008 · CA · contact PI
GENETIC ANALYSIS AND SAMPLE HANDLING$292,852
P01 · FY2008 · CA · contact PI
Bracing the Patellofemoral Osteoarthritis: A Clinical Trial$247,850
P60 · FY2008 · AR · contact PI
Correlating Environmental & Genetic Risk Factors with Molecular Signatures in$243,822
P50 · FY2008 · CA · contact PI
Folate, 1-Carbon Nutrients, Gene Variants & Colon Cancer$50,000
U54 · FY2008 · CA · contact PI
Image-based Measures for Osteoarthritis$28,244
R13 · FY2008 · AR · contact PI
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3$1,331,791
U01 · FY2007 · CA · contact PI
Folate, 1-Carbon Nutrients, Gene Variants & Colon Cancer$1,300,214
U54 · FY2007 · CA · contact PI
Cohort Study of Genetic Susceptibility to Breast Cancer$405,093
R01 · FY2007 · CA · contact PI
GENETIC ANALYSIS AND SAMPLE HANDLING$295,539
P01 · FY2007 · CA · contact PI
THERAPY FOR TREATMENT OF MEDIAL KNEE ARTHRITIS$106,263
M01 · FY2007 · RR · contact PI
Folate, 1-Carbon Nutrients, Gene Variants & Colon Cancer$1,511,739
U54 · FY2006 · CA · contact PI
Breast & Prostate Cancer & Hormone-Related Gene Variants$1,271,770
U01 · FY2006 · CA · contact PI
Cohort Study of Genetic Susceptibility to Breast Cancer$452,877
R01 · FY2006 · CA · contact PI
GENETIC ANALYSIS AND SAMPLE HANDLING$176,310
P01 · FY2006 · CA · contact PI
A RANDOMIZED TRIAL OF REALIGNMENT THERAPY FOR TREATMENT OF MEDIAL KNEE ARTHRITIS$28,181
M01 · FY2006 · RR · contact PI
Folate, 1-Carbon Nutrients, Gene Variants &Colon Cancer$1,448,273
U54 · FY2005 · CA
Breast &Prostate Cancer &Hormone-Related Gene Variants$1,340,396
U01 · FY2005 · CA
Cohort Study of Genetic Susceptibility to Breast Cancer$450,594
R01 · FY2005 · CA
COHORT STUDY OF GENETIC MARKERS IN COLON CANCER$280,210
R01 · FY2005 · CA
GENETIC ANALYSIS AND SAMPLE HANDLING$171,177
P01 · FY2005 · CA
Breast &Prostate Cancer &Hormone-Related Gene Variants$1,466,945
U01 · FY2004 · CA
Folate, 1-Carbon Nutrients, Gene Variants &Colon Cancer$1,321,772
U54 · FY2004 · CA
Cohort Study of Genetic Susceptibility to Breast Cancer$435,276
R01 · FY2004 · CA
COHORT STUDY OF GENETIC MARKERS IN COLON CANCER$281,208
R01 · FY2004 · CA
Fenoldopam: Effect and Contrast-Induced Renal Impairment$2,218
M01 · FY2004 · RR
Folate, 1-Carbon Nutrients, Gene Variants &Colon Cancer$1,379,462
U54 · FY2003 · CA
Breast &Prostate Cancer &Hormone-Related Gene Variants$1,303,157
U01 · FY2003 · CA
Cohort Study of Genetic Susceptibility to Breast Cancer$422,926
R01 · FY2003 · CA
COHORT STUDY OF GENETIC MARKERS IN COLON CANCER$273,360
R01 · FY2003 · CA
DNA repair, genetic variation and skin cancer$66,921
R03 · FY2003 · CA
Cohort Study of Genetic Susceptibility to Breast Cancer$452,731
R01 · FY2002 · CA
COHORT STUDY OF GENETIC MARKERS IN COLON CANCER$283,121
R01 · FY2002 · CA
POOLING OF PROSPECTIVE STUDIES OF DIET AND CANCER$279,549
P01 · FY2002 · CA
Risk Factors for Endometriosis$81,000
R03 · FY2002 · HD
DNA repair, genetic variation and skin cancer$67,666
R03 · FY2002 · CA
CORE--GENOTYPING AND DNA STORAGE$0
P01 · FY2002 · CA
CORE--GENOTYPING AND DNA STORAGE$0
P01 · FY2002 · CA
COHORT STUDY OF GENETIC MARKERS IN COLON CANCER$284,089
R01 · FY2001 · CA
POOLING OF PROSPECTIVE STUDIES OF DIET AND CANCER$279,549
P01 · FY2001 · CA
Risk Factors for Endometriosis$80,909
R03 · FY2001 · HD
CORE--GENOTYPING AND DNA STORAGE$0
P01 · FY2001 · CA
COHORT STUDY OF GENETIC SUSCEPTIBILITY TO BREAST CANCER$607,007
R01 · FY2000 · CA
CORE--GENOTYPING AND DNA STORAGE$0
P01 · FY2000 · CA